Mesirow Financial Investment Management International Equity »

Intensity Therapeutics shares owned by Mesirow Financial Investment Management International Equity

Quarter-by-quarter ownership of Intensity Therapeutics (INTS) shares owned by Mesirow Financial Investment Management International Equity from 13F filings

Historical chart of Mesirow Financial Investment Management International Equity investment in Intensity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intensity Therapeutics held by Mesirow Financial Investment Management International Equity consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intensity Therapeutics by Mesirow Financial Investment Management International Equity

Quarter filed Position value Share count Share price at filing
2024-03-31 $230k 44k 5.20

More positions owned by Mesirow Financial Investment Management International Equity

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Apple (AAPL)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Whitehall Fds High Div Yld (VYM)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Mesirow Financial Investment Management International Equity

Top funds holding Intensity Therapeutics

Sapient Capital
Vanguard Group
Brown Advisory Holdings Incorporated
Sigma Planning
Geode Capital Management
Mesirow Financial Investment Management International Equity
One Charles Private Wealth Services
Sentinus
Lakeview Capital Partners
Qube Research & Technologies
BlackRock
Commonwealth Equity Services
Jpmorgan Chase & Co
Tower Research Capital
UBS Group

View all funds holding Intensity Therapeutics